USPTO trademark

MEDERA

Opposition periodUSPTOWord markClass 42Class 44

"MEDERA" is a word mark owned by Medera Inc., filed at the USPTO on February 11, 2025. It is in its opposition period and covers classes 42 and 44.

Official USPTO record
MEDERA trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 23, 2026
Filed
February 11, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99036193
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns MEDERA

The owner and representative on file with the office.

Owner

Medera Inc.

Boston, Cayman Islands

Representative

Anna Kurian Shaw

Hogan Lovells US LLP

Goods and services

What the mark covers

The products and services MEDERA is filed for, grouped by Nice class.

  • Bacteriological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biological research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Biomedical research services for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Chemical research for others for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research in the nature of conducting clinical trials for others; Conducting early evaluations for others in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Development of biopharmaceutical preparations and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Drug discovery services for others; Engineering services for others, particularly technical project planning and design engineering of lines for the processing of web products; Industrial research for others in the field of regenerative and reparative gene and cell therapies; Medical research laboratory services for others; Pharmaceutical research services for others; Pharmaceutical drug development services for others for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Pharmaceutical product evaluation for others; Providing medical and scientific research information for others in the field of pharmaceuticals and clinical trials; Research and development of new products for others; Research and development of vaccines and medicines for gene and cell therapies for others for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; Scientific research for others in the field of gene therapy; Stem cell research services for others; Technical research for others in the field of pharmaceutical studies; Technology research for others in the field of regenerative gene and cell therapies

  • Blood bank services; Human tissue bank services; Organ and tissue bank services; Stem cell therapy services; Medical services; Consultancy in the field of the medical treatment and diagnosis of cardiovascular diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Extension of time to oppose process - terminated
  2. Opposition instituted no. 999999
  3. Extension of time to oppose received
  4. Official gazette publication confirmation e-mailed
  5. Published for opposition
  6. Notification of notice of publication e-mailed
  7. Approved for pub - principal register
  8. Examiner's amendment entered
  9. Notification of examiners amendment e-mailed
  10. Examiners amendment e-mailed

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About MEDERA

Who owns the trademark "MEDERA"?

The USPTO trademark "MEDERA" (application 99036193) is owned by Medera Inc.

What is the status of "MEDERA"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MEDERA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2a70-f1cf-727a-b32c-e6d83fc2571a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a70-f1cf-727a-b32c-e6d83fc2571a",
  "object": "trademark",
  "mark_text": "MEDERA",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99036193",
  "filing_date": "2025-02-11",
  "nice_classes": [
    42,
    44
  ],
  "owners": [
    {
      "name": "Medera Inc.",
      "entity_id": null
    }
  ]
}